ASMB - CIK 0001426800
ASSEMBLY BIOSCIENCES, INC. (ASMB) reported net income of -$6.12M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2025 | -$6.12M | +84.8% |
| FY 2024 | -$40.18M | +34.4% |
| FY 2023 | -$61.23M | +34.2% |
| FY 2022 | -$93.09M | +28.3% |
| FY 2021 | -$129.85M | -108.9% |
| FY 2020 | -$62.15M | +36.3% |
| FY 2019 | -$97.63M | -7.6% |
| FY 2018 | -$90.75M | -112.0% |
| FY 2017 |
ASSEMBLY BIOSCIENCES, INC. (ASMB) reported net income of -$6.12M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2011 and fiscal 2025, ASSEMBLY BIOSCIENCES, INC.'s net income grew from -$34.34M to -$6.12M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| -$42.81M |
| +3.3% |
| FY 2016 | -$44.26M | -55.6% |
| FY 2015 | -$28.45M | -19.6% |
| FY 2014 | -$23.79M | -22.6% |
| FY 2013 | -$19.40M | +21.7% |
| FY 2012 | -$24.79M | +27.8% |
| FY 2011 | -$34.34M | - |